AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 AUG 13 - (NewsRx.com & NewsRx.net) -- Therapeutic vaccines to treat human papillomavirus-associated disease are currently under development.
"There is a high prevalence of diseases caused by human papillomavirus (HPV) infection. Unfortunately, current treatments are inadequate. However, because there is evidence to support a role for the immune system in host defense against this virus, an immunotherapeutic approach is warranted," a researcher in Canada reports.
"The existing immunotherapies are not completely effective, nor are they durable," said N. Randall Chu at Stressgen Biotechnologies Corporation. "In addition, natural history studies associated with spontaneous regression have provided little guidance to the design of successful interventions. This state of knowledge has encouraged efforts towards the development of novel immunotherapeutic strategies. Successful preclinical studies of therapeutic vaccine candidates have led to clinical studies for a variety of HPV-associated indications, such as anogenital warts and cervical and anal intraepithelial neoplasia."
...
Source: HighBeam Research, Vaccines to treat human papillomavirus-associated disease under...